Company: BIVIW
Filing Date: 2025-07-11
Form Type: S-1/A
Source: 0001520138-25-000205
Chunk: 133

Company: BIOVIE INC.
Filing Date: 2025-07-11
Form: S-1/A
Chunk 133
---
 Section 13(d)
or Section 16 of the Exchange Act) would exceed 4.99% of the number of shares of our Common Stock outstanding immediately after giving
effect to the exercise, as such percentage ownership is determined in accordance with the terms of such warrant, which percentage may
be increased or decreased at the holder’s election upon 61 days’ notice to the Company subject to the terms of such warrants, provided that such percentage may in no event exceed 9.99%.

Exercise Price

The exercise price of our shares of our Common
Stock purchasable upon the exercise of the Pre-funded Warrants is $0.0001 per share. The exercise price of the Pre-funded Warrants and
the number of shares of our Common Stock issuable upon exercise of the Pre-funded Warrants is subject to appropriate adjustment in the
event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting our
shares of Common Stock, as well as upon any distribution of assets, including cash, stock or other property, to our stockholders.

Transferability

Subject to applicable laws, the Pre-funded Warrants
may be offered for sale, sold, transferred or assigned without our consent.

Exchange Listing

We do not intend to list the Pre-funded Warrants
on Nasdaq, any other national securities exchange or any other nationally recognized trading system.

Fundamental Transactions

Upon the consummation of a fundamental transaction
(as described in the Pre-funded Warrants, and generally including any reorganization, recapitalization or reclassification of our shares
of Common Stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or
merger with or into another person, the acquisition of more than 50% of our outstanding shares of Common Stock, or any person or group
becoming the beneficial owner of 50% of the voting power of our outstanding shares of Common Stock), the holders of the Pre-funded Warrants
will be entitled to receive, upon exercise of the Pre-funded Warrants, the kind and amount of securities, cash or other property that
such holders would have received had they exercised the Pre-funded Warrants immediately prior to such fundamental transaction, without
regard to any limitations on exercise contained in the Pre-funded Warrants. Notwithstanding the foregoing, in the event of a fundamental
transaction where the consideration consists solely of cash, solely of marketable securities or a combination of cash and marketable securities,
then each Pre